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Abstract
Background: Streptococcus equi subsp. zooepidemicus (S. zooepidemicus) is a commensal of horses
and an opportunistic pathogen in many animals and humans. Some strains produce copious
amounts of hyaluronic acid, making S. zooepidemicus an important industrial microorganism for the
production of this valuable biopolymer used in the pharmaceutical and cosmetic industry.
Encapsulation by hyaluronic acid is considered an important virulence factor in other streptococci,
though the importance in S. zooepidemicus remains poorly understood. Proteomics may provide a
better understanding of virulence factors in S. zooepidemicus, facilitate the design of better
diagnostics and treatments, and guide engineering of superior production strains.
Results: Using hyaluronidase to remove the capsule and by optimising cellular lysis, a reference
map for S. zooepidemicus was completed. This protocol significantly increased protein recovery,
allowing for visualisation of 682 spots and the identification of 86 proteins using mass spectrometry
(LC-ESI-MS/MS and MALDI-TOF/TOF); of which 16 were membrane proteins.
Conclusion: The data presented constitute the first reference map for S. zooepidemicus and
provide new information on the identity and characteristics of the more abundantly expressed
proteins.
Background
Streptococcus equi subsp. zooepidemicus (S. zooepidemicus) is
a commensal of the upper respiratory tract, skin and uro-
genital tract of horses, some other animals and humans. It
is a primarily opportunistic pathogen in many animal
species, including domesticated animals such as horses,
cows, pigs, sheep, and dogs. It is the primary cause of
equine respiratory tract infections in foals and the leading
cause of infertility in mares [1,2]. Sequencing of strain
H70 by the Sanger Institute was sponsored by The Horser-
ace Betting Levy Board in UK.
S. zooepidemicus also infects humans, typically through
zoonotic transmission from domesticated animals or by
ingestion of improperly pasteurised dairy products [3].
Clinical manifestations in humans include mild respira-
tory disease, pneumonia, endocarditis, endophthalmitis,
septic arthritis, meningitis, septicemia, streptococcal toxic
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shock syndrome and post-streptococcal glomerulonephri-
tis. A large outbreak with 253 cases of acute nephritis in
Brazil was linked to the consumption of unpasteurised
cheese and a strain isolate, MGCS10565, was recently
sequenced [4].
Lancefield Group A and C streptococci produce the
exopolysaccharide hyaluronic acid (HA). The HA capsule
protects streptococci from phagocytosis [5-8] and may
facilitate tissue adherence and invasion [5,9]. The HA cap-
sule is an important virulence factor for S. pyogenes and
disruption of the has operon results in a significant reduc-
tion in pathogenicity [10,11]. Similarly, the HA capsule
significantly enhances virulence of S. equi subsp. equi (S.
equi), a pathogenic biovar of S. zooepidemicus that causes
strangles in horses [8,12]. Whereas virulent isolates of S.
equi are generally highly encapsulated, capsule synthesis is
highly variable in S. zooepidemicus and usually lost follow-
ing primary culture, suggesting that encapsulation is
under regulation by host factors [13]. In S. pyogenes, HA
production as well as other virulence factors, are regulated
by the CsrRS protein (also known as CovRS). CsrRS is a
two-component regulator of extracellular virulence factors
in Group A streptococcus [14,15] and can be induced by
a human antimicrobial peptide [16].
The strain used in this study, ATCC 35246, was isolated
during 1975 Sichuan province swine streptococcosis out-
break, in which over 300,000 pigs died [17,18]. ATCC
35246 is a highly encapsulated S. zooepidemicus strain with
a stable mucoid phenotype even in the absence of selec-
tion [19]. Non-mucoid variants generated in continuous
culture on complex medium are similarly stable in serial
passage without selection, but revert to a mucoid pheno-
type when exposed to horse serum [19].
The objective of this study was to develop a proteomics
protocol and a reference map. The results can be used for
comparative analysis of mucoid and non-mucoid strains,
in order to better understand the role of HA regulation in
S. zooepidemicus virulence, facilitate the design of better
diagnostics and treatments [20], and guide engineering of
superior HA production strains [21].
Despite advances in mass spectrometry-based techniques
for proteomics analysis, two dimension gel electrophore-
sis (2-DE) is still the most commonly used protein sepa-
ration technique, especially with the use of new
fluorescent dye systems which enable differential gel elec-
trophoresis (2-D DIGE) [22]. 2-DE-based proteome anal-
yses have been performed for many microorganisms
including the closely related S. mutans [23], S. pneumoniae
[24], S. thermophilus [25,26], S. pyogenes [27-31] and more
recently S. suis [32]. There is currently no reference map
for S. zooepidemicus, though an extracellular immunopro-
teome map was recently reported for ATCC 35246 [18].
Obtaining high quality 2-DE gels and harvesting protein
extracts from encapsulated bacteria has proven to be tech-
nically challenging [24]. S. zooepidemicus ATCC 35246
produces very large amounts of high molecular weight
HA, which presents several technical challenges not found
in other streptococci: first, the buoyancy of HA limits the
formation of a cellular pellet by centrifugation; second,
the complex structure of the cell envelope enables the cell
to resist conventional lysis methods [24]; and thirdly, HA
interferes with standard protein extraction techniques.
In this paper we present a novel method that combines
capsular removal using enzymatic digestion (hyaluroni-
dase) with mechanical cell lysis, followed by protein
extraction and a precipitation technique that minimizes
protein loss. Proteins resolved from S. zooepidemicus strain
ATCC 35246 were further identified using LC-MS/MS and
MALDI-TOF/TOF to create the first reference map compat-
ible with DIGE of any streptococcal species.
Results and discussion
Hyaluronidase treatment combined with optimised 
extraction and precipitation techniques yields high-quality 
proteomic gels
Proteomic investigation of HA-encapsulated bacteria is
problematic because HA buoyancy limits the formation of
a cellular pellet by centrifugation and residual HA in pro-
tein extractions can interfere with subsequent analyses. In
HA-contaminated samples, protein quantification by
Bradford assay and 2D-Quant (GE Healthcare) were inac-
curate, resulting in overloaded gels. HA also interfered
with iso-electric focusing and poor quality 2-D gels were
observed even after protein precipitation (Figure 1A). In
solution, HA folds into a helical structure formed by
hydrogen bonds between carboxyl groups and N-acetyl
groups [33]. These hydrogen bonds form protein aggre-
gates and secondary structures that interfere with the
mobility in the gel; therefore, in our samples it was neces-
sary to remove HA prior to protein extraction. The use of
hyaluronidase to remove the HA capsule prior to protein
extraction allowed accurate protein quantification using
2D-Quant and improved iso-electric focussing.
Surface proteins are often immunogenic [30,31,34], and
are important in a proteome study. However, a lysis buffer
designed to isolate streptococcal membrane proteins
[24,35] (lysis buffer B) did not effectively denature pro-
teins and gave poor DIGE results (data not shown). There-
fore, a conventional lysis buffer (buffer A), which is
compatible with DIGE, was used. In combination with
hyaluronidase treatment, the conventional lysis buffer AProteome Science 2009, 7:13 http://www.proteomesci.com/content/7/1/13
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allowed us to obtain high quality gels suitable for pro-
teomic analysis (Figure 1B).
Samples for 2-DE should also be free of contaminants
(salts, ionic detergents, lipids, polysaccharides, DNA and
RNA). Furthermore, for 2-D DIGE, high protein concen-
trations are required. Protein precipitation has proven to
be a valuable tool to concentrate samples and remove
impurities; however, it is necessary that the precipitation
technique does not cause artifacts such as variable protein
losses resulting in a change in relative abundance of pro-
teins. We compared precipitation protocols based on ace-
tone or TCA as well as a commercial precipitation kit (2-
D Clean-Up; GE-Healthcare). The best results were
obtained with the 2-D Clean-Up kit; we observed a two-
fold increase in protein recovery, clearer gels and better-
resolved spots compared to the other techniques (data not
shown). The combination of hyaluronidase treatment,
conventional lysis (using buffer A) and 2-D Clean-Up
allowed for separation of 682 proteins of S. zooepidemicus
(Figure 2). The procedure was also reproducible between
replicate extractions, showing only slight variation in spot
numbers detected on each gel (625,622 and 619). Result-
ing protein spots were also compatible with DIGE and MS
identification techniques (see below). This protocol can
be used for comparative analysis of mucoid and non-
mucoid strains, in order to elucidate the role of HA in S.
zooepidemicus virulence.
Reference Map of the S. zooepidemicus proteome
Protein reference maps have proven to be valuable tools
to investigate protein expression in cells, tissues and
whole microorganisms. After obtaining good quality 2-
DE gels, proteins need to be identified and MS remains
the best technique to achieve this. The most abundant
spots in the gel were digested with trypsin and analysed
with LC-ESI-MS/MS. Where LC-ESI-MS/MS identified pro-
teins with less than our threshold of 99% confidence,
results were confirmed by MALDI-MS-TOF/TOF. From the
682 visualised proteins, a total of 86 proteins were identi-
fied from the reference map in 73 spots; 18 spots con-
tained more than one protein and eight proteins were
identified in multiple spots (Figure 2). The number of
identified proteins is similar to the 77 proteins recently
identified in the reference map for S. suis [32]. Enzymes
were grouped according to source pathway (glycolysis,
pentose phosphate, and HA pathways) or biomass prod-
uct type (amino acids, lipids and peptidoglycan synthesis)
(Figure 3). Identified proteins included four enzymes of
the HA pathway: UDP-N-acetyl-glucosamine pyrophos-
phorylase (EC 2.7.7.23; Spot 20), UDP-glucose pyrophos-
phorylase (EC 2.7.7.9; Spot 31), phosphoglucosamine
mutase (EC 5.4.2.10; Spot 55) and UDP-glucose dehydro-
genase (EC 1.1.1.22; Spot 80 and 34).
Good proteome reference maps are needed because in sil-
ico predictions fail to predict post-translational modifica-
tions, proteolyic cleavage and non-ideal electrophoretic
2-DE gels of S. zooepiodemicus Figure 1
2-DE gels of S. zooepidemicus. Proteins were separated using pH gradient 4–7 on 7 cm 12% polyacrylamide gels. Following 
separation, proteins were stained with silver nitrate. When HA was not removed, poor quality, streaky gels were obtained (A); 
digestion of HA prior to protein extraction resulted in high quality, streak-free gels (B).Proteome Science 2009, 7:13 http://www.proteomesci.com/content/7/1/13
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separation. Eight proteins were identified in multiple
spots (195978702, 195977350, 195978812, 19597756,
195977347, 195978812, 195977545, 195977347). Such
shifts can be caused by modifications such as phosphor-
ylation, glycosylation or acetylation, which can alter
molecular weight and/or pI. For all identified proteins,
theoretical pI and molecular masses were calculated using
an ExPASy tool and compared with experimental data.
The variation between predicted and measured pI was less
than 0.5 for most proteins with greater pI variation seen
towards the most basic region of the gel. The variation
between calculated molecular mass and experimental
data was low (within 10%) with the greatest variation
observed for masses greater than 55 kDa. It is possible that
some of the observed differences are due to genomic vari-
ations between MGCS10565 and ATCC 35246.
Seven of the proteins isolated were identified as hypothet-
ical proteins. Using InterProScan Sequence Search (EMBL-
EBI; http://www.ebi.ac.uk/Tools/InterProScan/) to iden-
tify protein properties (families, domains, repeats and
sites), one protein was identified as belonging to a phos-
photransferase system (195977564) and another contain-
ing the catalytic region of a diacylglycerol kinase
Reference map of S zooepidemicus (ATCC 35246) Figure 2
Reference map of S. zooepidemicus (ATCC 35246). Proteins were harvested using hyaluronidase to remove the HA cap-
sule. Proteins were separated using pH gradient 4–7 and 24 cm 12% polyacrylamide gels. Proteins were labelled with cy3 and 
visualised using a typhoon scanner. Protein spots identified using LC-ESI-MS/MS and MALDI-TOF/TOF numbered and listed in 
Additional file 1. Numbers not listed in the Additional file did not yield an MS-identified protein hit.Proteome Science 2009, 7:13 http://www.proteomesci.com/content/7/1/13
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(195978835). The function of the other proteins remains
unknown; localising these proteins on our reference map
may contribute to future understanding of their function.
Curiously, one of the proteins isolated (spot 2; Additional
file 1) could not be identified in the S. zooepidemicus
genome. When BLASTed against the Swiss Prot database,
the protein was most closely related to a Cu-Zn superox-
ide dismutase (SOD) (EC 1.15.1.1) from Bos mutus grun-
niens. Identification was confirmed by MALDI-MS-TOF/
TOF. We suspected this to be a contamination from the
hyaluronidase that was used to digest HA, which was
derived from a bovine source. Upon further review, two
bands were observed in SDS-PAGE of the hyaluronidase
and MS identification of the second band confirmed that
the SOD was a contaminant from the hyaluronidase prep-
aration (data not shown).
Surface proteome
The surface proteome is important for the identification
of vaccine candidates and virulence factors involved in
invasive infection [20,36]. In the complete S. zooepidemi-
cus  genome MGCS10565, 45 (2%) cell wall proteins,
1002 (44%) cytoplasmic proteins, 379 (16%) cytoplas-
mic membrane proteins, 185 (7%) extracellular proteins
and 703 (31%) undetermined localization proteins were
identified using the PSORTb 2.0 algorithm [37]. Of the 86
proteins identified in this study, 16 were predicted to be
membrane proteins and two to be extracellular proteins
(Additional file 1).
The surface proteome of S. zooepidemicus ATCC 35246 has
recently been assessed for immunogenicity [18]. 2-DE gels
of extracted extracellular proteins were blotted with con-
valescent sera raised in S. zooepidemicus-immunized SFP
minipigs and eight immunoreactive proteins identified.
Of these eight proteins, four were also identified in our
analysis: phosphoglycerate kinase (EC 2.7.2.3; PGK; Spot
34), UDP-N-acetyl-glucosamine pyrophosphorylase
(E2.7.7.23; Spot 20), UDP-glucose pyrophosphorylase
(EC 2.7.7.9; Spot 31) and phosphofructokinase (EC
2.7.1.11; Spot 28). Moreover, the strain has also recently
been used to develop a vaccine that protected mice [38]
and the M-protein of S. zooepidemicus has been found to
be distinct from other subspecies [17].
Seventeen of the proteins identified in our study were also
found in the extracted surface proteome of S. pyogenes
[29]. This represent a quarter of the 66 identified surface
proteins with known function and includes 10 out of the
33 immunoreactive proteins. Among these, the two heat
shock proteins – DnaK (Spot 1 and 60) and GroEL (Spot
59 and 82) – have previously been shown to be immuno-
genic for S. pyogenes [39,40] and were also identified in the
extracted surface proteome of S. agalactiae [41]. Phos-
phoglycerate kinase (EC 2.7.2.3; Spot 34) was also identi-
fied in the surface proteome of S. agalactiae and anti-sera
against phosphoglycerate kinase offers a degree of protec-
tion in a neonatal mice model [41].
2-DE based proteomics – whether based on whole-cell or
surface extraction – is not ideal for the identification of
surface proteins, due either to hydrophobicity and aggre-
gation during IEF, or their low abundance [20]. Some of
the surface exposed proteins of S. zooepidemicus have pro-
line-rich repeats that hinder migration in gels. Moreover,
extracted surface proteomes suffer from contamination
with abundant cytosolic proteins. Indeed, only 7 of the 66
identified surface proteins in the extracted surface pro-
teome of S. pyogenes had identifiable signal peptides [29].
In contrast, when the S. pyogenes surface proteome was
explored by protease treatment of whole-cells and identi-
fication of resulting peptides, only 4 of 72 proteins were
identified as cytoplasmic [30].
None of the reported S. zooepidemicus surface proteins
ZAG, FNZ and SzP previously considered as vaccine com-
ponents [17,42,43] were identified in the extracellular
immunoproteome of S. zooepidemicus ATCC 35246 [18]
or in our study. The 2-DE protocol developed here for
whole-cell extracts should be complemented with a more
targeted surface peptide MS method for a complete study
of virulence factors and identification of immunogenic
proteins capable of contributing to acquired protective
immunity.
Functional grouping of proteins identified from S. zooepidemi- cus proteome Figure 3
Functional grouping of proteins identified from S. 
zooepidemicus proteome. Proteins from the glycolysis, 
pentose phosphate, and HA pathways were identified in the 
reference map. Biomass constituent enzymes such as amino 
acid, lipids and peptidoglycan synthesis were also identified. 
HA: hyaluronic acid, PPP: phosphate pentose pathway; AA: 
amino acid.Proteome Science 2009, 7:13 http://www.proteomesci.com/content/7/1/13
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Conclusion
Presented here is the first proteomic reference map of an
important pathogenic microorganism, S. zooepidemicus.
We have developed an optimised protocol for HA
removal, cell lysis, protein precipitation and solubilisa-
tion; the protocol is compatible with DIGE and MS. A
comparison with the extracellular immunoproteome of S.
zooepidemicus and S. pyogenes suggests that the protocol
can be used to identify immunogenic membrane proteins
of potential use in vaccines. Both 2-DE approaches, how-
ever, suffer from a bias towards abundant membrane pro-
teins and possible contaminants and fail to identify low-
abundant, strongly immunogenic surface proteins such as
SzP.
The protocol will find immediate use in the comparison
of mucoid and non-mucoid strain variants of S. zooepi-
demicus, which will help to better understand the role of
HA regulation in S. zooepidemicus virulence as well as for
the design of superior production strains for HA produc-
tion. Four enzymes from the HA pathway were mapped in
this study: UDP-N-acetyl-glucosamine pyrophosphory-
lase (two copies), phosphoglucosamine mutase, glucose-
6-phosphate isomerase and UDP-glucose dehydrogenase.
The use of this reference map for metabolic engineering of
the strain is currently ongoing in our laboratory, and has
resulted in a provisional patent. Results of further studies
will be reported in the near future.
Methods
Strain culture
The mucoid Group C, S. zooepidemicus strain ATCC 35246
was obtained from the American Type Culture Collection
(Rockville, MD, USA). To ensure the mucoid phenotype,
cultures were grown in sheep blood agar and transferred
into a chemically defined medium modified from [44] by
adding 20 g L-1 of glucose, 4.5 g L-1 of acetate and 50 mg L-
1 of uridine. Growth experiments were conducted in a 2 L
bioreactor (Applikon) at a working volume of 1.4 L and
37°C. The reactor was agitated at 300 rpm and anaerobic
conditions were maintained by top sparging with nitro-
gen during fermentation. The pH was controlled at 6.7 by
addition of 5 M NaOH.
Lysis buffer
Cells were grown to exponential phase (OD530 = 2–4). In
some cases, hyaluronidase (10 mg per 100 mL) was added
and the cells incubated at 37°C for 10 min. Cells with
hyaluronidase treatment were centrifuged at 20,000 × g
for 20 min at 4°C and the pellet resuspended in 30 mL
lysis buffer A or B. Cells without hyaluronidase treatment
were centrifuged at 50,000 × g for 20 min at 4°C. Because
of its rheological properties and buoyancy, cells sur-
rounded by HA need a higher centrifugal force than cells
treated with hyaluronidase. Subsequently, the pellet was
resuspended in 30 mL wash buffer (50 mM NaH2PO4, 5
mM EDTA, 10% (v/v) glycerol, pH 7) to remove any resid-
ual medium. Cells were then pelleted again and resus-
pended in 5 mL lysis buffer A or B. Lysis buffer A is a
standard lysis buffer consisting of 30 mM Tris, 7 M urea, 2
M thiourea, 4% CHAPS and protease inhibitor cocktail
(Sigma-Aldrich). Lysis buffer B, which targets membrane
proteins (e.g. HA synthase), was modified from [35] and
consists of 50 mM NaH2PO4 (pH 7), 5 mM EDTA, 4 mg
mL-1 lysozyme, 10% (v/v) glycerol and protease inhibitor
cocktail (Sigma Aldrich). Cells were then transferred to a
disruption tube containing 1.44 g of 100 μm glass beads
and lysed using a Mini bead beater (Biospec Products Inc.)
In order to prevent samples from overheating, five sets of
one minute cycles at 48,000 rpm were performed with
samples chilled in ice water for one minute between beat-
ings. Cellular debris was removed by centrifugation at
13,000 × g for 10 min at 4°C and the supernatant stored
at -80°C.
Sample clean-up
Several methods were tested to determine the best precip-
itation method prior to cell extraction, including a com-
mercial 2-D clean-up (GE-Healthcare), acetone
precipitation [45] and TCA/acetone precipitation [46].
After precipitation, proteins were resuspended in lysis
buffer A. The protein concentration in the supernatant
was determined using the Bradford assay or 2-D Quant kit
(GE-Healthcare) according to the manufacturer's instruc-
tions.
Two Dimension electrophoresis
Iso-electric focusing (IEF) was performed using IPG strips
(GE-Healthcare). For silver-staining and DIGE, 50 μg or 8
μg of protein were loaded into 24 or 7 cm strips (pH 4–7),
respectively. DIGE staining was performed according to
manufacturer's instructions using a Typhoon 9410 imager
(GE Healthcare) for image analysis. For MS, Coomassie
staining was used and 500–800 μg protein was loaded
into 24 cm gels by in-gel rehydration. Proteins were sepa-
rated on an IPGphore I unit (GE, Healthcare) by active
rehydration, (30 V) for 12 hrs prior to IEF. IEF was per-
formed according to the following protocol: 1 h, 500 V
(Step and hold); 1 h, 1000 V (gradient); 3 hrs, 8000 V
(gradient); 12 hrs, 8000 V (Step and hold). After equili-
bration [47], IPG strips were embedded on top of 12%
polyacrylamide gels and electrophoresed in an Ettan Dalt
12 electrophoresis unit (GE Healthcare) at 2 W gel-1for 30
min, followed by 18 W gel-1 for 6 hrs. After electrophore-
sis, gels were fixed in 10% (v/v) acetic acid and 30% etha-
nol for 1 hr and then stained.
Gel images were analysed using Progenesis SameSpots
(Nonlinear dynamics, Newcastle, UK) as described else-Proteome Science 2009, 7:13 http://www.proteomesci.com/content/7/1/13
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where [48]. Gels were overlaid by warping and fused to a
reference image using the Progenesis algorithm.
Trypsin digestion, LC-ESI-MS/MS and MALDI-MS-TOF/
TOF
Protein spots were excised from the gel and digested with
an excess of trypsin (Trypsin Gold, MS grade; Promega)
overnight at 37°C as described previously [49]. Peptides
were dried using a SpeedVac (SPD111V, Thermo Savant)
and redissolved in 80 μL 5% formic acid (aqueous) for MS
analysis. An Agilent 1100 Binary HPLC system (Agilent)
was used to perform reversed phase separation of the sam-
ples prior to MS using a Vydac MS C18 300A, column
(150 mm × 2 mm) with a particle size of 5 μm (Vydac). A
30 μL aliquot of sample was injected onto the HPLC col-
umn. The mobile phase consisted of solvent A (0.1%
aqueous formic acid) and solvent B (90/10 acetonitrile/
0.1% aqueous formic acid). Tryptic peptides were eluted
using a gradient elution programme of 0–40% B in 80
min, 40–80% B in 10 min and finally a 5 min hold at 80%
B, followed by a return to 0% B for a 10-min equilibra-
tion. The flow rate was 200 μL min-1. Eluate from the RP-
HPLC column was directly introduced into the TurboIon-
Spray source.
Mass spectrometry experiments were performed on a
hybrid quadrupole/linear ion trap 4000 QTRAP MS/MS
system (Applied Biosystems). The 4000 QTRAP equipped
with a TurboIonSpray Source was operated in positive
electrospray ionization mode. All analyses were per-
formed using Information Dependent Acquisition and
the linear ion trap (LIT) acquisition modes. Analyst 1.4.1
software was used for data analysis. The acquisition proto-
col used to provide mass spectral data for database search-
ing involved the following procedure: mass profiling of
the HPLC eluant using Enhanced Multiple Scan (EMS),
ions over the background threshold were subjected to
examination using the Enhanced Resolution scan (ER) to
confirm charge states of the multiply charged molecular
ions. The most and next most abundant ions in each of
these scans with a charge state of +2 to +3 or with
unknown charge were subjected to CID using rolling col-
lision energy. An enhanced product ion scan was used to
collate fragment ions and present the product ion spec-
trum for subsequent database searches (see details
below).
Additionally, some samples were analysed by MALDI-MS
using a 4700 Proteomics Analyzer MALDI-TOF/TOF
(Applied Biosystems). When necessary, the samples were
first desalted using micro C18 ZipTips (Millipore), and
peptides eluted directly with 5 mg mL-1 of CHCA in 60%
ACN/0.1% aqueous formic acid onto a MALDI target
plate. All MS and MS/MS spectra were acquired as
reported earlier [50,51] with minor modifications. MS/
MS data acquisition was performed in a four-step process.
First, MS spectra were recorded from each of the six cali-
bration spots, and the default calibration parameters of
the instrument and the plate model for that plate were
updated. Secondly, MS spectra were recorded for all sam-
ple spots on the plate. Each spectrum was generated by
accumulating the data from 1000 laser shots, using the
newly updated default calibration settings. Thirdly, the
TOF-MS spectra were analyzed using the Peak Picker soft-
ware supplied with the instrument. The 10 most abundant
spectral peaks that met the threshold criteria (>20:1 sig-
nal:noise) and were not on the exclusion list were
included in the acquisition list for the TOF-TOF, MS/MS
portion of the experiment. The threshold criteria were set
as follows: mass range: 500 to 4000 Da; minimum cluster
area: 500; minimum signal-to-noise (S/N): 20; maximum
number of MS/MS spectra per spot: 10. A mass filter
excluding matrix cluster ions and trypsin autolysis peaks
was applied. An XML file was generated which contained
the list of the precursor masses selected for MS/MS.
Database searching
Database searching of LC-MS/MS, non-interpreted TOF-
MS and TOF-TOF MS/MS data was carried out using the
ProteinPilot software (version 2.0.1) and Paragon algo-
rithm (Applied Biosystems) in a similar fashion as
described elsewhere [52]. The genome of strain ATCC
35246 is not available and we used the published genome
for S. zooepidemicus MGCS10565 [4] as the main reference.
Since  S. zooepidemicus has been found to be extremely
diverse by multilocus sequence typing [53], we obtained
the final annotated genome sequence of the H70 strain
from the Sanger Institute. A paper describing the H70
genome has been accepted and the genome has been sub-
mitted to EMBL (pers. comm., Dr Julian Parkhill). The
final sequence without annotation is available from the
Sanger Institute ftp://ftp.sanger.ac.uk/pub/pathogens/sz/.
The MS/MS spectra were extracted and searched against
four databases: (i) two protein databases of S. zooepidemi-
cus (H70 and MGCS10565), (ii) a modified UniProt data-
base containing the S. zooepidemicus genome and (iii) a
custom-made database of S. zooepidemicus containing ran-
domly shuffled protein entries as a false-positive control.
The following search parameters were used: trypsin as
enzyme, no Cys modification and the protein confidence
threshold cut-off ProtScore 2.0 (unused), with at least two
peptides with 99% confidence (see Additional file 2).
Finally, PSORT was used to predict protein localization in
gram positive bacteria [37].
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